A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States
- PMID: 28083237
- PMCID: PMC4945297
A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States
Abstract
Vaccine-preventable disease continues to take a heavy toll on adults despite the widespread availability of effective vaccines. This article identifies where efforts to improve the delivery of adult vaccination have stalled and recommends targeted strategies that are supported by available evidence and build on existing infrastructure. The authors conducted a comprehensive review of the published literature on adult immunization, a stakeholder workshop, and follow-up interviews with meeting participants and additional experts. They also partnered with an organization represented at the workshop to conduct a telephone survey of adults to learn about the relationship between influenza vaccination and beliefs about the safety of influenza vaccine. Findings include that office-based providers remain the primary source of vaccination, though a substantial proportion of physicians who treat adults appear not to vaccinate at all and adult vaccination is infrequently discussed at health care encounters. Adult practices also lack a strong business case to offer vaccination, as it entails substantial fixed costs. In addition, achieving substantial increases in adult vaccination will require persuading large numbers of individuals disinclined to be vaccinated. Vaccination stakeholders need to engage in a collaborative fashion to promote adult vaccination and the integration of advice about vaccination into routine office-based practice. Recommendations include strengthening evidence surrounding practice gaps and the economic value of promoting vaccination in office-based settings, improving guidance to providers about vaccinating adults, and formalizing procedures for referring patients to complementary vaccinators.
Similar articles
-
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1. MMWR Surveill Summ. 2016. PMID: 26844596
-
Pediatricians' attitudes about collaborations with other community vaccinators in the delivery of seasonal influenza vaccine.Acad Pediatr. 2012 Jan-Feb;12(1):26-35. doi: 10.1016/j.acap.2011.07.004. Epub 2011 Sep 6. Acad Pediatr. 2012. PMID: 21900066
-
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8. MMWR Recomm Rep. 2009. PMID: 19713882
-
Challenges in adult vaccination.Ann Med. 2018 May;50(3):181-192. doi: 10.1080/07853890.2017.1417632. Epub 2018 Jan 16. Ann Med. 2018. PMID: 29338438 Review.
-
Practice-proven interventions to increase vaccination rates and broaden the immunization season.Am J Med. 2008 Jul;121(7 Suppl 2):S11-21. doi: 10.1016/j.amjmed.2008.05.003. Am J Med. 2008. PMID: 18589063 Review.
Cited by
-
Stakeholder perspective and sentiment in a rapidly growing United States adult vaccination environment.iScience. 2025 Feb 17;28(3):112009. doi: 10.1016/j.isci.2025.112009. eCollection 2025 Mar 21. iScience. 2025. PMID: 40124500 Free PMC article.
-
The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.Public Health Rep. 2015 Jan-Feb;130(1):10-42. doi: 10.1177/003335491513000104. Public Health Rep. 2015. PMID: 25552752 Free PMC article. No abstract available.
-
Exploring the future adult vaccine landscape-crowded schedules and new dynamics.NPJ Vaccines. 2024 Feb 9;9(1):27. doi: 10.1038/s41541-024-00809-z. NPJ Vaccines. 2024. PMID: 38336933 Free PMC article. Review.
-
The relationship between influenza vaccination habits and location of vaccination.PLoS One. 2014 Dec 9;9(12):e114863. doi: 10.1371/journal.pone.0114863. eCollection 2014. PLoS One. 2014. PMID: 25490092 Free PMC article.
-
Archetype analysis of older adult immunization decision-making and implementation in 34 countries.Vaccine. 2020 May 27;38(26):4170-4182. doi: 10.1016/j.vaccine.2020.04.027. Epub 2020 Apr 16. Vaccine. 2020. PMID: 32376108 Free PMC article.
References
-
- Davis, M., Wortley P., Ndiaye S., Cowan A., Osta A., andClark S., “Influenza Vaccine for High-Risk Non-Elderly Adults: A National Survey of Subspecialists,” Human Vaccines, Vol. 4, No. 3, 2008, pp. 229–233. - PubMed
-
- Freed, G., Clark S., Cowana A., andColemand M., “Primary Care Physician Perspectives on Providing Adult Vaccines,” Vaccine, Vol. 29, 2011, pp. 1850–1854. - PubMed
-
- Hurley, L. P., Lindley M. C., Harpaz R., Stokley S., Daley M. F., Crane L. A., Dong F., Beaty B. L., Tan L., Babbel C., Dickinson L. M., andKempe A., “Barriers to the Use of Herpes Zoster Vaccine,” Annals of Internal Medicine, Vol. 152, No. 9, 2010, pp. 555–560. - PubMed
LinkOut - more resources
Full Text Sources